These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9589046)
21. [Diagnostic value of DNA ploidy in epithelial elevated lesions of the stomach]. Nakano O; Fujimaki E; Orii S; Chiba S; Yamashiki H; Fujino Y; Tazawa H; Sato K; Sato S; Sasaki K Gan To Kagaku Ryoho; 1993 Apr; 20(6):804-7. PubMed ID: 8489289 [TBL] [Abstract][Full Text] [Related]
22. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance. Berho M; Viciana AL; Poppiti RJ; Ruiz P J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236 [TBL] [Abstract][Full Text] [Related]
23. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited. Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293 [TBL] [Abstract][Full Text] [Related]
24. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1. Masood S; Bui MM; Lu L Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198 [TBL] [Abstract][Full Text] [Related]
25. Predictive value of flow cytometry for metastatic potential in breast cancer. Schmidt H; Wei JP; Yeh KA Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212 [TBL] [Abstract][Full Text] [Related]
26. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix. Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380 [TBL] [Abstract][Full Text] [Related]
27. DNA ploidy and TLI in association with other prognostic parameters in breast cancer. Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571 [TBL] [Abstract][Full Text] [Related]
28. Biological indicators of aggressiveness in T1 ductal invasive breast cancer. Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792 [TBL] [Abstract][Full Text] [Related]
29. Response to Beerman et al.: "Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer". Kute T Cytometry; 1991; 12(2):155-6. PubMed ID: 2049972 [No Abstract] [Full Text] [Related]
30. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341 [TBL] [Abstract][Full Text] [Related]
31. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603 [TBL] [Abstract][Full Text] [Related]
32. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix. Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420 [TBL] [Abstract][Full Text] [Related]
33. [Analysis for predicting the prognostic factors of gastrointestinal tract leiomyosarcoma using MIB-1 and DNA flow cytometry]. Nishio T; Nakagomi H; Mutou S; Miyake T; Hagiwara J; Ashizawa I; Oyama T; Takano K; Tada Y Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():475-80. PubMed ID: 9589056 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of DNA flow cytometric analysis in patients with nasopharyngeal carcinoma. Yip TT; Lau WH; Chan JK; Ngan RK; Poon YF; Lung CW; Lo TY; Ho JH Cancer; 1998 Dec; 83(11):2284-92. PubMed ID: 9840527 [TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483 [TBL] [Abstract][Full Text] [Related]
36. Cellular DNA contact and its correlation with histopathological prognostic parameters in carcinoma of the breast. Chaturvedi S; Singh S; Khanna HD; Khanna S; Khanna R Indian J Pathol Microbiol; 1998 Jul; 41(3):337-42. PubMed ID: 9805857 [TBL] [Abstract][Full Text] [Related]
37. [Impact of DNA image cytometry (ICM) parameter and established prognostic factors on disease free survival (DFS) and overall survival (OS) of node-negative breast cancer (NNBC) patients]. Schlotter CM; Vogt U; Bosse U; Wassmann K Zentralbl Gynakol; 2003 Sep; 125(9):368-74. PubMed ID: 14569519 [TBL] [Abstract][Full Text] [Related]
38. DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma. al-Alwan NA East Mediterr Health J; 2000; 6(5-6):1062-72. PubMed ID: 12197329 [TBL] [Abstract][Full Text] [Related]